VR Logo

Syngene International Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

38 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Scientific research and development

Incorporated: 1993

Chairman: --

Managing Director: Kiran Mazumdar Shaw

Group: --

Listing: NSE: SYNGENE, BSE: 539268

Headquarters: Bengaluru, Karnataka

Website: www.syngeneintl.com

Key Facts

Market cap: R 12,236.00 Cr

Revenue (TTM): R 1,938.50 Cr

Earnings (TTM): R 392.00 Cr

Cash: R 1,152.90 Cr

Total Debt: R 813.30 Cr

Promoters' ownership: 70.70%

Liquidity: High

52 Week range: R 280.25 - 369.00

Face value: R10.00

Shares outstanding: 40,00,00,000

Stock Performance

Time Period Syngene International S&P BSE Healthcare* S&P BSE Mid Cap*
YTD-4.227.344.64
1 month-1.435.181.67
3 months-4.2811.556.69
1 Year4.694.8811.02
3 Years5.89-1.335.49
5 Years---1.897.83
10 Years--11.679.16
As on 17-Feb-2020 *As on 14-Feb-2020
Year Syngene International S&P BSE Mid Cap S&P BSE Healthcare
201914.86-3.05-3.55
20183.46-13.31-5.89
2017-3.6548.130.49
201634.517.97-12.88

Review & Analysis